Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications [0.03%]
维多珠单抗治疗溃疡性结肠炎的疗效与免疫细胞互作相关联
Paul Hsu,Eunice J Choi,Shefali A Patel et al.
Paul Hsu et al.
Background: Ulcerative colitis (UC) and Crohn's disease are 2 types of inflammatory bowel disease (IBD), a group of chronic digestive disorders caused by aberrant immune responses to intestinal microbes. Although changes ...
3D Imaging and Printing in Inflammatory Bowel Diseases: Limitations, Barriers, and Opportunities Toward "Haute Couture" Surgical Approaches [0.03%]
炎症性肠病中的三维成像和打印：走向“高级定制”手术方式的局限性、障碍和机遇
Gianluca Pellino,Alvaro García-Granero
Gianluca Pellino
Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study [0.03%]
儿童炎症性肠病患者疾病严重程度和病变分布的床旁肠系膜超声预测：横断面研究试点项目
Mallory Chavannes,Lara Hart,Panteha Hayati Rezvan et al.
Mallory Chavannes et al.
Background: Intestinal ultrasound (IUS) is a noninvasive tool to assess bowel inflammation. There is a paucity of data on its accuracy in pediatric patients. ...
Katie Hsia,Naisi Zhao,Mei Chung et al.
Katie Hsia et al.
Background: Although gut fungi have been implicated in the immunopathogenesis of inflammatory bowel disease, the fungal microbiome has not been deeply explored across endohistologic activity and treatment exposure in ulce...
1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure [0.03%]
溃疡性结肠炎抗肿瘤坏死因子失败患者的托法替尼与乌司奴单抗疗效的1年比较研究
Rahul S Dalal,Puza P Sharma,Kanwal Bains et al.
Rahul S Dalal et al.
Background: Tofacitinib is an oral Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Real-world data comparing the effectiveness of tofacitinib to ustekinumab are limited. We compared 52-week outcomes o...
Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology [0.03%]
肠源性结直肠癌的分子发病学：免疫、遗传与肠道微生态
Yue Yin,Jian Wan,Jingmin Yu et al.
Yue Yin et al.
Patients with inflammatory bowel disease (IBD) have a high risk for colorectal cancer (CRC). This cancer type, which is strongly associated with chronic inflammation, is called colitis-associated CRC (CAC). Understanding the molecular patho...
Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease [0.03%]
生物制剂在炎症性肠病管理中的前置审批制度改革
Lauren Loeb,Ayan Nasir,Michael F Picco et al.
Lauren Loeb et al.
Ruiqi Ma,Yijun Zhu,Xiaozhi Li et al.
Ruiqi Ma et al.
Background: A distinctive metabolic phenotype provides the opportunity to discover noninvasive biomarkers for the diagnosis of Crohn's disease (CD) and for differentiating it from other intestinal inflammatory diseases. T...
Upadacitinib as a Novel Treatment in Therapy Refractory Collagenous Colitis [0.03%]
乌帕西利治疗难治性胶原性结肠炎的新型疗法
Leo Boneschansker,Kristin E Burke
Leo Boneschansker